Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
株式のランク #26670
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
株価
$5.54
最終同期: 2024-09-18
時価総額
$38.76M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Alimera Sciences, Inc. (ALIM)

カテゴリー

Alimera Sciences, Inc.(ALIM)の営業利益率
August 2026 時点の営業利益率 TTM: -2.39%
Alimera Sciences, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -2.39% です。2022 年末時点では -21.50% でした。
Alimera Sciences, Inc. の営業利益率の履歴(2006 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -2.39% 0.00%
2023 -2.39% -88.88%
2022 -21.50% 6,223.53%
2021 -0.34% -65.66%
2020 -0.99% -89.88%
2019 -9.78% -52.50%
2018 -20.59% -55.05%
2017 -45.81% -43.52%
2016 -81.11% -53.33%
2015 -173.81% -55.57%
2014 -391.16% -78.72%
2013 -1,837.82% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
同業他社の営業利益率
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。